Ironwood Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,301
Closed -$208K 278
2026
Q1
$208K Sell
2,301
-216
-9% -$19.8K 0.03% 260
2025
Q4
$226K Buy
2,517
+43
+2% +$4.08K 0.03% 251
2025
Q3
$244K Buy
2,474
+280
+13% +$27.7K 0.04% 240
2025
Q2
$200K Buy
2,194
+16
+0.7% +$1.55K 0.03% 252
2025
Q1
$247K Buy
+2,178
New +$233K 0.04% 215
2024
Q2
Sell
-1,603
Closed -$212K 267
2024
Q1
$212K Buy
+1,603
New +$200K 0.04% 244
2023
Q3
Sell
-1,443
Closed -$210K 259
2023
Q2
$210K Buy
+1,443
New +$196K 0.05% 197

Other funds holding ZBH

Ironwood Investment Counsel's ZBH Position: Q2 2026 in Review

Ironwood Investment Counsel sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,301 shares — an estimated $208K sold.

Ironwood Investment Counsel first reported a position in ZBH in Q2 2023 and held it in 7 quarters. The position peaked at $247K in Q1 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ironwood Investment Counsel reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Ironwood Investment Counsel sold 2,301 Zimmer Biomet shares in Q2 2026, an estimated $208K.
  • Ironwood Investment Counsel first reported a position in Zimmer Biomet in Q2 2023 and held it in 7 quarters.
  • Ironwood Investment Counsel's Zimmer Biomet position peaked at $247K in Q1 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.